Ted Lamson

Ted Lamson is an accomplished professional with extensive experience in the medical technology sector. Currently serving as a Board Member at Eximis Surgical and Palette Life Sciences, and a Strategic Advisor for Calyxo, Inc., Lamson has been influential in various roles including Consultant at Teleflex Incorporated and Strategic Advisor at EXPLORAMED DEVELOPMENT LLC. Notably, Lamson is a Commercial Council Member at Moximed since January 2024, and previously held the position of Founder and Chief Technical Officer at NeoTract, where significant fundraisers included $22M in a Series A and $28M in a Series B. Earlier career roles include VP of Advanced Technologies at Medtronic Vascular and VP of R&D at TransVascular. Lamson holds a PhD and MS in Bioengineering from Penn State University and a BS in Chemical Engineering from Rensselaer Polytechnic Institute.